Health
Johnson & Johnson trials show single-shot COVID-19 vaccine effective; hoping for emergency use OK soon – WSOC Charlotte
A COVID-19 vaccine produced by Johnson & Johnson is provoking an immune response in human trials and is showing it is effective in fighting the virus that has killed…
Studies on the companys one-dose vaccine showed it would produce neutralizing antibodies, or antibodies that fight the virus, soon after the drug was administered.
The vaccine was being tested on people aged 18-55. While common side effects of a vaccination — such as fever, fatigue, headache, and pain at the injection site — were seen in some people, those side effects were not severe.
Dr. Paul Stoffels, chief scientific officer at J&J, said the data gave the company confidence the vaccine will…
-
Noosa News14 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News14 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business19 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business18 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025